SUCCESS: Series of Unique Creative Continuing Education Self Studies

You are not logged in. (Login)



The P Blood Group and Unexpected Anti-PP1Pk in an Eleven Week Old Infant (release date 08/21/2018). This course explores the history and biology of the P blood group and also includes a case study.

IgG Structure and Function Effect on Hemolytic Disease of the Newborn and Neonatal Alloimmune Thrombocytopenia Severity (Release Date: 05/07/2018) Hemolytic Disease of the Newborn (HDN) and Neonatal Alloimmune Thrombocytopenia (NAIT) pose significant morbidity and mortality risk.  Prevention and early detection are key.  Recent studies have described a correlation between immunoglobulin structure and clinical severity.  Typical IgG structure and immunoglobulin structural alterations along with the study results will be presented.

Indications for Transfusion (Release Date: 06/14/2017) Indications are established reasons for transfusion, which will benefit the patient. However blood components are drugs and can have adverse effects and should not be administered indiscriminately. This course will highlight the main indications and some of the adverse effects that can occur with the transfusion of red blood cells, plasma, and platelets.

Practical Coagulation for the Blood Bank (Release date: 06/30/2016) This course provides a summary of the general coagulation model which includes initiation, amplification and propagation. There is also a look at thrombin’s role in clot formation as well as a review of the common coagulation tests and the major drugs used in coagulation abnormalities.

An Introduction to Pathogen Reduction (Release date: 08/31/2016) This course defines the concept of pathogen reduction, describes the pathogen reduction systems available for blood components and summarizes the studies conducted to date.

FDA Draft Guidance on Platelet Safety (release date: 09/19/2017) This course review the significant elements of the FDA Draft Guidance on mitigation of bacterial contamination in platelets. This learning material also identifies the challenges for implementation of the proposed process changes and addresses how the Final Guidance may appear after public comments have been submitted and reviewed.